Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial

The polypill strategy was cost-saving compared to usual care among patients with or at high risk of CVD in India.